key: cord-0818810-hpncmfcx authors: Sadeghmoghadam, Leila; Daneshfar, Majid; Sharifi, Farshad; Alizad, Vida title: How the first cases of COVID-19 in 10 countries become infected? a case series date: 2020-09-16 journal: Respir Med Case Rep DOI: 10.1016/j.rmcr.2020.101219 sha: eebea6843a5df9d4f1aef66cd81034ac4454ddc2 doc_id: 818810 cord_uid: hpncmfcx Recently, a new respiratory infectious disease called COVID-19 has emerged and created a global emergency. It was initially linked to the animal-to-human transmission. However, it is now thought that COVID-19 is spreading through human-to-human transmission mainly via droplets. As there is no definite antiviral therapy for the treatment of cases with COVID-19 the best option for slowing down the pandemic and reducing mortality rates is protection against the virus of interest. To achieve this goal obtaining information about how first cases infected with COVID-19 is crucial. Hence, this study aims to review the studies published in peer-reviewed journals to report the first confirmed cases with COVID-19. Herein, we review the origin, symptoms, diagnostic tests, and progress of the disease and possible actions of authorities which would be effective in similar pandemics in the future. This study reviewed 13 cases (5 females and 8 males; 25-61 years old) from 10 countries. All cases have recovered from COVID-19. The results of this review suggested that timely reports of the confirmed cases, notifying World Health Organization and providing information to the general population about the methods of spreading the virus would have decreased the number of infected cases and mortality rates. In addition, the travel history of the first confirmed cases in various countries suggested that prompt actions in restricting travels and closing borders could be an efficient strategy in preventing the transmission of the disease outside of the affected sites. Efforts should be taken by health authorities for preparing the world for future epidemic/pandemic in terms of developing advanced screening strategies in the borders and diagnostic strategies for early identification of infected cases. The underlying cause of COVID-19 has not been fully understood. It is thought that the original 33 cause of COVID-19 was linked to bats similar to the previous SARS-Cov and MERS-Cov 34 epidemics. It has also been suggested that snakes can act as intermediate hosts to transfer 35 COVID-19 from bats to humans (1). Given the high incidence and prevalence of the disease, 36 growing human-animal interface, genetic diversity and recombination events across the genomes 37 (3), the outbreak of COVID-19 is likely undertaken by super shaping phenomenon as previously 38 suggested as the main cause for spreading . COVID-19 is other organs (5-7). Given a large number of infected people and mortality rates caused by the COVID-19 crisis, 50 many countries have adopted restrictive measures to minimize the number of cases and death, 51 yet the numbers are still increasing in some countries. The increasing number of cases and death 52 along with the strict restrictive measures together affects people's mental health and well-being. Therefore, it is critical to identify possible modes of transmission to be equipped with efficient 54 precaution recommendations and infection prevention guidelines to minimize infection 55 transmission and related consequences on the quality of lives of people in future similar 56 situations. Hence, the present paper reviews all peer-reviewed studies that reported the first cases 57 of COVID-19 disease diagnosed in 11 countries between 05 January 2020 and 09 February 2020. Such an analysis provides a better understanding of the spreading mechanism of the virus and 59 provides information for preparedness, early identification of cases and secondary prevention in were not reported by the authors (4). Nepal was one of the countries bordered with China that reported its first case of 2019-nCoV. The first infected patient with COVID-19 virus in Nepal was a 32-year man who was a 85 university student in Wuhan, without any underlying conditions and no history of exposure to infusion and empiric antibiotic with ceftriaxone (2 gm everyday intravenously and 2 gm loading) followed by oral amoxicillin/clavulanate 875/125 mg every 12 h on the 8th day of admission to 119 hospital. One week later her real-time RT-PCR of sputum specimens yielded negative results and 120 remained negative 6 days later and serial X-ray and chest CT scan revealed tenacious COVID-19 121 pneumonia and sequelae. The patient discharged on the 28th day of the illness after 17 days of 122 hospitalization when the results of the tests returned negative for SARS-CoV-2 (9). Another case was a 25-year-old Vietnamese woman who traveled to Wuhan and stayed there for 124 2 months with two Vietnamese friends. They confirmed that they did not have any exposure to Further, in cases with negative nucleic acid testing and with a rapid progression of chest 212 imaging, repeated nucleic acid testing is required to confirm the diagnosis of COVID-19. Another important finding was that none of these cases developed severe symptoms. They 214 visited the hospitals as they had seen a health alert from the governments, or they were screened In conclusion, no consistent set of symptoms was found. However, flu-like symptoms were 294 found to be predictors of new cases. The lack of typical pneumonia is not a reason for postponing 295 chest X-ray or CT scan as there were cases that were diagnosed only because of the early chest 296 CT scans that showed early stages of pneumonia. From a policy-making point of view, analyzing 297 and understanding which strategies are optimal in the prevention of infectious diseases may help 298 to achieve better results in the future. This warrants further investigation and analyzing the 299 lessons taken from the COVID-19 pandemic. Regarding the mild cases, it is possible that the 300 mild symptoms particularly the ones which are not accompanied by shortness of breathing might 301 not be taken seriously by the infected cases 302 303 The authors declare that they do not have conflict of interest. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak 2019-nCoV (Wuhan virus), a 317 novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine 318 readiness Updates on 320 Wuhan 2019 novel coronavirus epidemic Wuhan novel coronavirus (COVID-19): why global control is challenging? Public 322 health Clinical display, 324 diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic Acute respiratory distress 327 syndrome in COVID-19 disease. Immunopathol Persa. 2020; e16 Is Coronavirus Disease 330 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection The first 2019 335 novel coronavirus case in Nepal. The Lancet Infectious Diseases First case 337 of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan The first Vietnamese 15 First imported case of 2019 novel 351 coronavirus in Canada, presenting as mild pneumonia. The Lancet America: The implications of the first confirmed case in Brazil Lessons of mortality following COVID-19 epidemic in the United States 356 especially in the geriatrics Trend of case fatality rate during first 30 359 days of COVID-19 epidemic; the example of Iran Estimating the asymptomatic 361 proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond 362 Princess cruise ship New hope for treatment of 365 respiratory involvement following COVID-19 by bromhexine This study was supported by Tehran University of Medical Sciences, Tehran, Iran.